Based on their analyses, researchers call for prioritizing clinical trials of drugs targeting the proteins IFNAR2 and ACE2 to treat COVID-19 in its early stages
A crucial part of the global effort to stem the spread of the pandemic is the development of tests that can rapidly identify infections in asymptomatic people
Scientists have developed an algorithm that automatically corrects for the biases in data that stem from an overrepresentation of male subjects in clinical trials
We’ve updated our Privacy Policy to make it clearer how we use your personal data.
Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.